2Ravi R, Somani SM, Rabak LP, et al. Mechanism of cisplaitn ototoxicity: antioxidant system. Pharmacol Toxicol, 1995, 76, 386-394.
3Rabak LP, Husain K, Whitworth C, et al. Dose dependent protection by lipoic acide against cisplatin-induced ototoxicity in rats, antioxidant defense system. Toxicol Sci, 1999, 47:195-202.
4Rabak LP, whitworth C, Somani S, et al. Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope, 1999,109 : 1740-1744.
5Fleischman RW, Standnicki SW, Ethier M, et al. Ototoxicity of cis-diammindichloroplatin Ⅱ in the guinea pig. Toxicol Appl Pharmacol, 1975, 33:320-332.
6Schweitzer VG, Dolan DF, Abrams GE, et al. Amelioration of cisplatin-induced ototoxicity by fosfomycin,Laryngoscope, 1986, 96: 948-958.
7Saito T, Manabe Y, Honda N, et al. Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs. Scanning Microsc, 1995,9:271-281.
8Schweitzer VG. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope,1993, 103:1-52.
9Church MW, Kahenbach JA, Blakley BW, et al. The comparative effects of sodium thiosulfate, diethldithiocarbamate, fosofomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity. Hear Res, 1995, 86. 195-203.
10Campbell GW, Meech RP, Rybak LP, et al. D-methionine protects against cisplatin damage to the stria vascularis. Hear Res, 1999, 138:13-28.
